Introduction
Acute kidney injury (AKI) is a complex disorder that occurs in a variety of settings with clinical manifestations ranging C The Author [2008] . Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org from a minimal elevation in the serum creatinine (Cr) to anuric renal failure [1] . Among all patients admitted to the hospital, the incidence of AKI is known to be ∼1% at the time of admission and 2-5% during the hospitalization [2] . It is well known that ∼40% of all cases of AKI are intrinsic AKI directly involving the renal parenchyma; these cases are usually caused by ischaemic or toxic acute tubular necrosis (ATN). Most cases of AKI in the intensive care unit are caused by sepsis [3] . The reactive oxygen species (ROS) have been implicated as important effectors of tubule cell injury in both ischaemic and toxic acute tubular necrosis [4] . The ROS have numerous deleterious effects on cells, including lipid peroxidation, oxidation of cell proteins and damage to the DNA [5] . However, it is difficult to identify the single most important effect of ROS on the renal tubules in vivo, because multiple factors play a role in the development of AKI.
Paraquat (PQ) (1,1 -dimethyl-4,4 -bipyridinium dichloride) is used as a non-selective herbicide. Accidental or intentional ingestion of PQ is frequently fatal within a few days due to multiple organ failure mediated by ROS [6, 7] . PQ is considered one of the most dangerous and controversial herbicides in the world. The EU Court of First Instance prohibited the use of PQ in the EU in July 2007. Elsewhere, PQ is currently the most common herbicide in other countries. Acute PQ intoxication is unique in causing a clinical condition due to the ROS. A high concentration of PQ in cells results in abnormal redox cycling and generates the toxic ROS [8] . Both lung and kidney injuries have been well established as the major causes of death after PQ poisoning. With this, we hypothesize that the AKI caused by acute PQ poisoning might provide a clinical model for ROS-induced AKI. In this study, we analysed the clinical features of 278 patients with acute PQ intoxication, focusing on renal function deterioration.
Materials and methods

Study population
This study was approved by Soonchunhyang Cheonan Hospital's Investigational Review Board. From January 2007 to December 2007, 296 patients (169 males and 127 females) with acute PQ intoxication were admitted to the Institute of Pesticide Poisoning, at the Soonchunhyang Hospital (SCH) in Cheonan, Korea. These patients either presented to our hospital or were transferred from another hospital. Among them, 278 cases (158 males and 120 females) were enrolled in this study. Eighteen patients, who were excluded, had unstable vital signs or were in a very poor physical condition within 1 day of ingestion. A urine dithionite test and/or plasma PQ level test by HPLC were performed in all patients.
Data collection and study variables
Trained physicians treated the patients and recorded all information on a standardized data-collection form. All data were reviewed by two pesticide specialists. On admission, a standardized questionnaire including demographic characteristics and specific questions about the PQ poisoning (amount of PQ ingestion, time interval between ingestion and SCH arrival) was completed. The amount of PQ ingestion was defined as one mouthful to 20 mL. Standardized medical emergency procedures were performed and are summarized in Table 1 . The demographics of the 278 patients with acute PQ poisoning are summarized in Table 2 . 
Definition of AKI and assessment of clinical features of PQ-induced AKI
All of the patients had their blood Cr levels, arterial blood gas analysis and urine output checked daily during the hospitalization. The definition of AKI was based on the RIFLE (risk, injury, failure, loss and end stage) criteria and the changes in the levels of serum Cr, as proposed by the ADQI group [9] : 150-200% of basal level (risk category), 200-300% of basal level (injury category) and >300% and/or >4 mg/dL (failure category). The initial parameters of the 278 patients at the time of arrival at SCH were compared between patients in the initial serum Cr ≤1.2 mg/dL group and those in the initial serum Cr >1.2 mg/dL group. The patients in the initial Cr ≤1.2 mg/dL group were divided according to the RI-FLE criteria into failure group (failure) and non-failure group (normal, risk, injury). The clinical features and mortality of the failure group were compared to those of the non-failure group and the results were analysed. Oliguric AKI was defined as a 24-h urine collection of <400 mL. Serial changes in the serum Cr were evaluated to follow the clinical features associated with PQinduced AKI. We investigated the frequency, initiation and duration of haemodialysis (HD), and analysed the mortality among patients with AKI who underwent HD. The nephrologist decided to perform HD (Gambro, Polyflux 6L, surface area 1.4 m 2 , session time 4 h, blood flow 250 mL/min, dialysate flow 500 mL/min) based on the general indications.
Next to be tested was the association of PQ-induced AKI with other multiorgan dysfunction (lung, liver and pancreas).
Similar to a previous report from our centre [10] , hepatic dysfunction was defined as an increase of aspartate aminotransferase (AST) or alanine aminotransferase (ALT) of more than two times upper normal limits. Pancreatic dysfunction was diagnosed when the serum amylase level and the serum lipase level were more than twice the upper normal limit. Respiratory failure was considered to be present when the arterial partial pressure of oxygen was <60 mmHg. 
Statistical analysis
Data are presented as mean ± standard deviation for continuous variables and frequency (in percent) for categorical variables. A probability value of P < 0.05 was considered statically significant. The statistical analysis was performed using SPSS for Windows (version 12.0, Chicago, IL, USA). The differences between groups were compared with Student's t-test for continuous variables and the chi-square test for categorical variables. A multiple logistic regression analysis was used to determine the factors affecting AKI after PQ poisoning. The strength of the association between the RIFLE classification and the outcome after PQ poisoning was expressed as an odds ratio.
Results
Relation between initial Cr levels and other parameters (Figure 1)
Age, time interval between PQ ingestion and the arrival time at the hospital, plasma PQ level, estimated amount of PQ ingestion, AST, blood urea nitrogen, serum Cr and uric acid were significantly lower in the patients in the initial Cr ≤1.2 mg/dL group compared to those in the initial (Figure 2 ). The results demonstrate that the initial serum Cr level was a very important prognostic factor for mortality [odds ratio 9.00, 95% C.I. (4.747, 17.061), P-value < 0.01].
Clinical features of AKI in patients with initial Cr ≤1.2 mg/dL
The incidence of AKI in patients in the initial Cr ≤1.2 mg/ dL group was 51.4% (89/173). Of these, Cr-measured failure occurred in 34.7% (60/173) (Figure 1 ). The average peak serum Cr level among the 13 survivors in the failure group was 4.38 mg/dL by the fifth day after PQ intoxication; their Cr levels normalized within 3 weeks of ingestion ( Figure 3) . None of the patients had permanent loss of renal function.
Oliguric AKI was observed in 10 patients. The development of oliguric AKI was noted on the third and fourth days after PQ ingestion, in two patients who survived among the 10 patients with oliguric AKI. After the fourth day, the urine output increased. All of the other patients expired. The number of patients who developed oliguric AKI was 1 on the second day, 2 on the third day, 3 on the fourth day and 2 on the fifth day.
The time interval between PQ ingestion and the arrival time at the hospital, the estimated amount of PQ ingestion, Cr levels, uric acid and PaO 2 were significantly higher in the failure group compared to the non-failure group among the patients who presented with initial Cr ≤1.2 mg/dL. In contrast, the PaCO 2 and HCO 3 − were significantly lower in the failure group than in the non-failure group (Table 4) . The survival rate was 13% (13/60) among the patients with failure and 84.07% among those without failure. The estimated amount of PQ ingestion and the time interval between PQ ingestion and the arrival time at the hospital were factors predictive of the incidence of AKI by the multiple logistic analysis ( 
Mortality according to RIFLE classification
The risk for mortality was significantly higher in the patients with failure than in those without failure. According to the RIFLE classification, patients with renal injury and failure had a higher mortality risk than did patients without AKI (Table 6 ).
The association of renal failure with other organ functions
The incidence of multiorgan dysfunction accompanying AKI was 36.67% (22/60) with pancreatic dysfunction, 51.67% (31/60) with hepatic dysfunction and 75% (45/60) with respiratory failure. The odds ratio for patients with AKI developing other organ failure was 15 
RIFLE classification in patients with initial Cr ≤1.2 mg/dL
Because 48 patients died within two days of presentation, 50 patients were analysed. Among these patients, failure was present in 25 (18 died), injury in 10 (7 died), risk in two (2 died), and non-AKI in 13 (9 died). There was no significant difference in mortality between patients with AKI and those without AKI [odds ratio 1, 95.0% C.I. (0.291, 3.437), P-value = 1]. In addition, there was no significant difference in mortality between patients with injury and those 
Discussion
To properly understand the pathophysiology of a disease, an experimental model of the disease is often needed. There have been many experimental models developed to study AKI including ischaemia, isolated perfusion kidney, radiocontrast, combined insults and drugs or endotoxin infusion [12] [13] [14] ; however, these models are based on animal investigations. PQ ingestion can be used to study the effects of ROS. Patients with PQ intoxication have a high mortality rate due to the effects of the ROS [15] . Therefore, the acute renal failure (ARF) associated with acute PQ poisoning might provide a good model for the clinical features of ROS-induced AKI. Renal insufficiency may exist in patients with initial Cr >1.2 mg/dL. We also analysed patients with initial Cr ≤1.2 mg/dL. Of the patients in the initial Cr ≤1.2 mg/ dL group, 84 had normal renal function throughout the study, 15 were at risk, 14 were having renal injury and 60 patients were considered to have failure. The incidence of PQ-induced AKI was 51.4%, and the incidence of failure was 34.68%. PQ is toxic to renal proximal tubule cells through the generation of ROS, which cause lipid peroxidation of the cell membrane, leading to loss of membrane integrity and cell death [16] . Although PQ can induce ATN, there is limited information about this in the medical literature [16, 17] .
Our data showed that the average peak serum Cr level was achieved on the fifth day after ingestion, and the Cr level normalized within 3 weeks. There were no significant differences in the initial laboratory parameters, age, gender, amount of ingestion, time lapse after ingestion and plasma PQ levels between the 10 patients who developed oliguric AKI and the 50 with non-oliguric AKI. It is necessary to investigate the factors involved in oliguric AKI.
As we previously reported [11, 18] , the data showed that the initial renal function was a very important factor for survival. Taken together with our previous reports, a very large portion of the PQ is excreted via renal filtration and secretion. Therefore, early renal preservation is very important.
Many clinical studies have shown that the RIFLE classification is a valid tool for predicting outcome [19, 20] . In addition, the presence of renal injury and failure, based on the RIFLE classification, predicts mortality in patients with PQ-induced AKI (Table 4) . However, risk was not a predictor of outcome in patients in the initial Cr ≤1.2 mg/ dL group. The patients at risk might have had subtle injuries that did not influence patient mortality after PQinduced AKI. Further investigation is necessary to study the validity of the RIFLE classification for drug-induced nephropathies. Of the patients with initially abnormal Cr levels, many died early and the baseline Cr of the patients was not known. Therefore, the RIFLE classification cannot be used for patients in the initial Cr >1.2 mg/dL group.
The factors most related to the development of failure were the estimated amount of PQ ingestion and the time interval between ingestion and the arrival time at the hospital. The increased incidence of AKI in patients arriving to the hospital in the shortest time might be due to the fact that patients who ingest more PQ tend to go to the hospital faster. Contrary to our expectation, the PQ level in serum showed no significant association with developing of AKI. We believe this was due to the various time intervals between PQ ingestion and blood sampling time for PQ measurement.
In cases with a potential for ROS formation in clinical setting, acute PQ intoxication is the strongest and most urgent cause of tissue injury mediated by ROS. In outpatients, some had drunk unbelievable amount (several hundred millilitres) of PQ. We believed that a lot of ROS formation was produced. However, all of the AKI reversed by 3 weeks. A single exposure of ROS to the kidney is clinically benign regardless of the amount, but results of repeated exposure is needed to be studied.
The limitations of this study include the following. To more completely describe the clinical features of the patients with AKI, a control group of patients with ischaemiaor toxin-induced AKI would be needed. But since it is, for all practical purposes, impossible to study such human subjects, our study was carried out without a control group. Another question is about the ROS formation in our patients. We have previously published that in in vitro examinations the amount of ROS that is formed is decided by a reaction between both PQ concentrations and the duration of PQ exposure. However, in the current study the interpretation of the clinical outcome of AKI was carried out on the assumption that ROS generation would be consistent with the amount of PQ ingestion and/or serum PQ level at admission, without measurement of ROS and/or ROS by-product.
In conclusion, the incidence of AKI with PQ intoxication was 51.4% and the incidence of failure was 34.7%. The amount of PQ ingested is the most important factor influencing the development of AKI after PQ intoxication. The clinical feature was characterized by fully developed AKI at the fifth day after PQ ingestion and normalized within 3 weeks without exception.
